FR2373513B1 - - Google Patents

Info

Publication number
FR2373513B1
FR2373513B1 FR7736662A FR7736662A FR2373513B1 FR 2373513 B1 FR2373513 B1 FR 2373513B1 FR 7736662 A FR7736662 A FR 7736662A FR 7736662 A FR7736662 A FR 7736662A FR 2373513 B1 FR2373513 B1 FR 2373513B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7736662A
Other languages
French (fr)
Other versions
FR2373513A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2373513A1 publication Critical patent/FR2373513A1/fr
Application granted granted Critical
Publication of FR2373513B1 publication Critical patent/FR2373513B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
FR7736662A 1976-12-07 1977-12-06 Nouveaux derives du naphtalene, leur preparation et leur application comme medicaments Granted FR2373513A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1535376 1976-12-07
CH8277 1977-01-05

Publications (2)

Publication Number Publication Date
FR2373513A1 FR2373513A1 (fr) 1978-07-07
FR2373513B1 true FR2373513B1 (US20020095090A1-20020718-M00002.png) 1980-08-22

Family

ID=25683446

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7736662A Granted FR2373513A1 (fr) 1976-12-07 1977-12-06 Nouveaux derives du naphtalene, leur preparation et leur application comme medicaments

Country Status (17)

Country Link
JP (1) JPS5384955A (US20020095090A1-20020718-M00002.png)
AT (1) AT366361B (US20020095090A1-20020718-M00002.png)
CA (1) CA1105475A (US20020095090A1-20020718-M00002.png)
DE (1) DE2752659A1 (US20020095090A1-20020718-M00002.png)
DK (1) DK527877A (US20020095090A1-20020718-M00002.png)
ES (1) ES464747A1 (US20020095090A1-20020718-M00002.png)
FI (1) FI773595A (US20020095090A1-20020718-M00002.png)
FR (1) FR2373513A1 (US20020095090A1-20020718-M00002.png)
GB (1) GB1597140A (US20020095090A1-20020718-M00002.png)
IE (1) IE45929B1 (US20020095090A1-20020718-M00002.png)
IL (1) IL53533A (US20020095090A1-20020718-M00002.png)
NL (1) NL7713364A (US20020095090A1-20020718-M00002.png)
NZ (1) NZ185884A (US20020095090A1-20020718-M00002.png)
PH (1) PH13932A (US20020095090A1-20020718-M00002.png)
PT (1) PT67365B (US20020095090A1-20020718-M00002.png)
SE (1) SE7713471L (US20020095090A1-20020718-M00002.png)
SU (1) SU927110A3 (US20020095090A1-20020718-M00002.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4402974A (en) 1981-06-23 1983-09-06 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS639500B2 (US20020095090A1-20020718-M00002.png) * 1978-07-14 1988-02-29 Amerikan Hosupitaru Sapurai Corp
US4314082A (en) * 1978-07-14 1982-02-02 American Hospital Supply Corporation Derivatives of 2-amino-6,7-dihydroxytetrahydro naphthalene (ADTN)
DE3062971D1 (en) 1979-09-14 1983-06-09 Sandoz Ag Derivatives of tetraline, their preparation and medicaments containing these compounds
EP0033789B1 (en) * 1980-01-30 1984-03-07 American Hospital Supply Corporation 2-alpha-methyl-dopaminimino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, its salts, and a process for preparation thereof
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
AU8455082A (en) * 1981-05-11 1982-12-07 Folk Lars-Erik Arvidsson Therapeutically useful tetralin derivatives iii,processes forpreparation and pharmaceutical preparations for such compounds
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche
US4500545A (en) * 1982-11-16 1985-02-19 Eli Lilly And Company Hydroxyaminotetralincarboxamides
US4448990A (en) * 1982-11-16 1984-05-15 Eli Lilly And Company Hydroxyaminotetralincarboxamides
US4743618A (en) * 1983-01-03 1988-05-10 Nelson Research & Development Co. Substituted 2-aminotetralins
US4722933A (en) * 1985-12-20 1988-02-02 Nelson Research & Development Co. Substituted 2-aminotetralins
US4564628A (en) * 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins
US4657925A (en) * 1984-08-13 1987-04-14 Nelson Research & Development Co. Method and compositions for reducing the intraocular pressure of mammals
US5177112A (en) * 1983-01-03 1993-01-05 Whitby Research, Inc. Substituted 2-aminotetralins
GB2157950B (en) * 1984-05-04 1988-11-02 Nelson Res & Dev Selective d-2 dopamine receptor agonist
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
CA1331191C (en) 1988-03-25 1994-08-02 Bengt Ronny Andersson Therapeutically useful tetralin derivatives
US5225596A (en) * 1989-01-09 1993-07-06 The Upjohn Company Halo substituted aminotetralins
JP2931986B2 (ja) * 1989-02-17 1999-08-09 武田薬品工業株式会社 アラルキルアミン誘導体
SE8901889D0 (sv) * 1989-05-26 1989-05-26 Astra Ab Novel 8-substituted-2-aminotetralines
AU650106B2 (en) * 1991-03-07 1994-06-09 Zeria Pharmaceutical Co., Ltd. Trialkylamine derivative and ameliorant for digestive tract movement containing the same
PT923542E (pt) * 1996-05-31 2003-12-31 Upjohn Co Aminas ciclicas substituidas no arilo como ligandos selectivos de dopamina d3
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
AR054363A1 (es) * 2005-05-23 2007-06-20 Astrazeneca Ab Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
JP5643467B2 (ja) * 2011-06-27 2014-12-17 シャンドン リュイェ ファーマシューティカル カンパニー リミテッドShan Dong Luye Pharmaceutical Co., Ltd. 窒素置換のアミノ−5,6,7,8−テトラヒドロナフトールの工業的製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1017359A (en) * 1972-07-03 1977-09-13 Frederic P. Hauck Substituted cyclic polymethylene phenols

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4402974A (en) 1981-06-23 1983-09-06 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents

Also Published As

Publication number Publication date
PH13932A (en) 1980-11-04
JPS6214540B2 (US20020095090A1-20020718-M00002.png) 1987-04-02
DK527877A (da) 1978-06-08
AT366361B (de) 1982-04-13
PT67365B (fr) 1979-09-20
SU927110A3 (ru) 1982-05-07
NZ185884A (en) 1980-04-28
IE45929B1 (en) 1982-12-29
IL53533A0 (en) 1978-03-10
DE2752659A1 (de) 1978-06-08
NL7713364A (nl) 1978-06-09
JPS5384955A (en) 1978-07-26
SE7713471L (sv) 1978-06-08
FI773595A (fi) 1978-06-08
CA1105475A (en) 1981-07-21
GB1597140A (en) 1981-09-03
IL53533A (en) 1982-07-30
FR2373513A1 (fr) 1978-07-07
PT67365A (fr) 1978-01-01
IE45929L (en) 1978-06-07
ES464747A1 (es) 1979-01-01
ATA871977A (de) 1981-08-15

Similar Documents

Publication Publication Date Title
FR2338430B1 (US20020095090A1-20020718-M00002.png)
FR2373513B1 (US20020095090A1-20020718-M00002.png)
DE2604219C2 (US20020095090A1-20020718-M00002.png)
JPS52119277U (US20020095090A1-20020718-M00002.png)
DE2607848A1 (US20020095090A1-20020718-M00002.png)
CS192684B1 (US20020095090A1-20020718-M00002.png)
CS178383B1 (US20020095090A1-20020718-M00002.png)
CS177780B1 (US20020095090A1-20020718-M00002.png)
CS176999B1 (US20020095090A1-20020718-M00002.png)
CS175503B1 (US20020095090A1-20020718-M00002.png)
CS175337B1 (US20020095090A1-20020718-M00002.png)
JPS52112483U (US20020095090A1-20020718-M00002.png)
CH611500A5 (US20020095090A1-20020718-M00002.png)
DD123189A1 (US20020095090A1-20020718-M00002.png)
CH603197A5 (US20020095090A1-20020718-M00002.png)
CH604237B5 (US20020095090A1-20020718-M00002.png)
CH604283A5 (US20020095090A1-20020718-M00002.png)
CH604630A5 (US20020095090A1-20020718-M00002.png)
CH604697A5 (US20020095090A1-20020718-M00002.png)
CH608568A5 (US20020095090A1-20020718-M00002.png)
CH610401A5 (US20020095090A1-20020718-M00002.png)
CH611213A5 (US20020095090A1-20020718-M00002.png)
CH611223A5 (US20020095090A1-20020718-M00002.png)
CH601480A5 (US20020095090A1-20020718-M00002.png)
CH613878A5 (US20020095090A1-20020718-M00002.png)

Legal Events

Date Code Title Description
ST Notification of lapse